首页 | 本学科首页   官方微博 | 高级检索  
检索        

美克治疗体股癣、手足癣、花斑癣和皮肤念珠菌病疗效观察
引用本文:缪仕栋,沈雅惠,孙鲁芳.美克治疗体股癣、手足癣、花斑癣和皮肤念珠菌病疗效观察[J].皮肤病与性病,2007,29(4):6-8.
作者姓名:缪仕栋  沈雅惠  孙鲁芳
作者单位:1. 福建省寿宁县中草药开发研究所,福建,寿宁,355500
2. 福建省寿宁县妇幼保健所
3. 福建省寿宁县医院
摘    要:目的评价美克(1%联苯苄唑乳膏)治疗体股癣、手足癣、花斑癣和皮肤念珠菌病的临床疗效和安全性。方法采用多中心、随机、平行对照的方法,试验组外用美克,对照组外用欣欣(1%盐酸布替萘芬乳膏)。结果体股癣患者停药时试验组与对照组痊愈率分别为42.20%和39.45%,有效率分别为94.49%和91.74%;停药2w时,试验组与对照组痊愈率分别为85.32%和82.56%,有效率分别为97.24%和96.33%。手足癣停药时试验组与对照组痊愈率分别为39.87%和37.34%,有效率分别为85.54%和84.81%;停药2w时,试验组与对照组痊愈率分别为59.49%和58.22%,有效率分别为89.24%和86.70%。花斑癣患者停药时试验组与对照组痊愈率分别为50.72%和52.17%,有效率分别为79.71%和76.81%;停药2w时,试验组与对照组痊愈率分别为66.67%和63.76%,有效率分别为84.05%和81.16%。皮肤念珠菌病患者停药时试验组与对照组痊愈率分别为34.88%和39.53%,有效率分别为72.09%和76.74%;停药2w时,试验组与对照组痊愈率分别为65.11%和67.44%,有效率分别为88.37%和86.04%。局部不良反应发生率各试验组合计为5.27%;各对照组合计为5.54%。上述各项指标,各病种试验组与对照组比较差异均无统计学意义。结论美克治疗体股癣、手足癣、花斑癣和皮肤念珠菌病安全有效。

关 键 词:体股癣  手足癣  花斑癣  皮肤念珠菌病  美克
文章编号:1002-1310(2007)04-0006-03
收稿时间:2007-01-09
修稿时间:2007年1月9日

Clinical study of bifonazole cream in the treatment of tinea corporis and cruris, tinea manus and pedis, tinea versicoior, canididiasis cutis
MIAO Shi-dong,SHEN Ya-hui,SUN Lu-fang.Clinical study of bifonazole cream in the treatment of tinea corporis and cruris, tinea manus and pedis, tinea versicoior, canididiasis cutis[J].Journal of Dermatology and Venereology,2007,29(4):6-8.
Authors:MIAO Shi-dong  SHEN Ya-hui  SUN Lu-fang
Abstract:Objective To investigate the efficacy and safely of bifonazole cream in the treatment of tinea corporis and cruris,tinea manus and pedis,tinea versicoior,canididiasis skin.Methods A randomized blind group trial was used.Results At the end of study,for tinea corporis and cruris,tinea,the overall cure rate,the response rates of the test group vs the control group were 42.20% vs 39.45%,94.49% vs 91.74%;Tinea manus and pedis patients were 39.87% vs 37.34%,85.44% vs 84.81%;Tinea versicoior patients were 50.72% vs 51.17%,79.71% vs 76.81%;Versicoior,canididiasis skinpatients were 34.88% vs 39.53%,72.09% vs 76.74%.Two weeks followup,for tinea cruris and tinea corporis were 85.32% vs 82.56% and 97.24% vs 96.33%;Tinea manus and pedis patients were 58.49% vs 58.22% and 89.24% vs 86.70%;Tinea versicoior patients were 66.67% vs 63.76% and 84.05% vs 81.16%;Canididiasis skin patients were 65.11% vs 67.44% and 88.37% vs 86.04%.The local adverse reaction rates of four test groups vs four control groups were 5.27% vs 5.54%.There were no statistically significant differences between four groups on alove-menitioned data.Conclusion Bifonazole cream is effective and well-tolerated in the treatment of tinea corporis and cruris,tinea manus and pedis,tinea versicoior,canididiasis skin.
Keywords:tinea corporis and cruris  tinea manus and pedis  tinea versicoior  canididiasis cutis bifonazole cream    
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号